US

5AM Ventures targets $350 mln for fourth fund

5AM Ventures is seeking to raise $350 million for its fourth fund, according to an SEC filing. Based in San Francisco and Boston, the venture firm invests in early-stage life science companies.

Humbition collects $30 mln for new fund

Humbition, a newly launched early-stage venture firm focused on founder-led companies in New York City, has raised $30 million for its new fund. Zocdoc founder Cyrus Massoumi and Indiegogo founder Slava Rubin lead Humbition.

Brex rakes in $125 mln Series C

San Francisco-based Brex, a corporate card for startups, has raised $125 million in Series C funding. Greenoaks Capital and DST Global led the round.

Fusion Coolant Systems nabs $8 mln Series C

Canton, Michigan-based Fusion Coolant Systems, a provider of advanced coolant and lubrication systems, has raised $8 million in Series C financing. Material Impact and Michigan Capital Advisors led the round with participation from other investors that included MINTS- Michigan Investment in New Technology Startups, Amherst Fund and Invest Michigan.

Stay Alfred inks $47 mln Series B

Stay Alfred, a provider of alternative accommodations for travelers, has secured $47 million in Series B funding. Nine Four Ventures led the round.

Huel grabs $26 mln from Highland Europe

UK-based Huel, a nutritionally complete meal alternative, has secured $26 million in funding. The investor was Highland Europe.

CSA Medical snags $15 mln venture loan facility from Horizon

Horizon Technology Finance Corp has provided a $15 million venture loan facility to CSA Medical Inc. Based in Lexington, Massachusetts, CSA Medical is a producer of cryotherapy medical devices.

Rylo raises $20 mln from Icon, Accel, Sequoia

Rylo said it raised $20 million of Series B funding in a round led by Icon Ventures and joined by Accel Partners and Sequoia Capital. The funding brings capital raised to $35 million.

Epiris wraps up new fund

UK-based private equity firm Epiris has closed its new fund at 821 million pounds. The fund's investors include public and private pension funds, endowments and foundations, asset managers and private investors. Campbell Lutyens was the financial adviser and placement agent.

VC-backed Guardant Health goes public

Redwood City, California-based Guardant Health, a liquid biopsy company, has raised $237.5 million for its IPO after pricing its 12.5 million shares at $19 per share. The stock began trading October 4, 2018 on the NASDAQ under the ticker symbol "GH." J.P. Morgan Securities LLC and BofA Merrill Lynch are the lead underwriters. Guardant Health's pre-IPO backers included SoftBank Vision Fund, Sequoia Capital, Khosla Ventures and Lightspeed Venture Partners.